Strumento inattivo

Altre lingue Genfit SA Xetra

Azioni

XUP

FR0004163111

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	05/07
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading	01/07
GENFIT : Document AMF CP. 2024E983694	01/07
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading	28/06
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	27/06
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher	21/06
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading	20/06
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	18/06
Inarrêtables	18/06
En Direct des Marchés : Renault, Alstom, Technip Energies, Séché, Shell, Boeing, Tesla...	18/06
Bolsa de Madrid: Imparable	18/06
GENFIT: New EASL EASD EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At Risk MASH	18/06
GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL EASD EASO pour la MASLD incluent NIS2+® comme outil clé pour la détection de la MASH à risque	17/06
GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque	17/06
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH	17/06
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading	14/06
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading	12/06
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading	11/06
Genfit S.A. Announces the Successful Corporate Milestone with U.S. FDA Accelerated Approval of Ipsen's Iqirvo for Primary Biliary Cholangitis	11/06
GENFIT : La FDA approuve l'Iqirvo d'Ipsen et Genfit contre la cholangite biliaire primitive	11/06

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Genfit SA Xetra

Azioni

XUP

FR0004163111

Altre lingue

Filtri